We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Journal of Comparative Effectiveness Research
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

A Bayesian approach to gene–gene and gene–environment interactions in chronic fatigue syndrome

    Eugene Lin

    † Author for correspondence

    Vita Genomics, Inc., 7th floor, No. 6, Sec. 1, Jung-Shing Road, Wugu Shiang, Taipei, Taiwan.

    &
    Sen-Yen Hsu

    Department of Psychiatry, Chi Mei Medical Center, Liouying, Tainan, Taiwan

    Published Online:https://doi.org/10.2217/14622416.10.1.35

    Introduction: In the study of genomics, it is essential to address gene–gene and gene–environment interactions for describing the complex traits that involves disease-related mechanisms. In this work, our goal is to detect gene–gene and gene–environment interactions resulting from the analysis of chronic fatigue syndrome patients’ genetic and demographic factors including SNPs, age, gender and BMI. Materials & methods: We employed the dataset that was original to the previous study by the Centers for Disease Control and Prevention Chronic Fatigue Syndrome Research Group. To investigate gene–gene and gene–environment interactions, we implemented a Bayesian based method for identifying significant interactions between factors. Here, we employed a two-stage Bayesian variable selection methodology based on Markov Chain Monte Carlo approaches. Results: By applying our Bayesian based approach, NR3C1 was found in the significant two-locus gene–gene effect model, as well as in the significant two-factor gene–environment effect model. Furthermore, a significant gene–environment interaction was identified between NR3C1 and gender. These results support the hypothesis that NR3C1 and gender may play a role in biological mechanisms associated with chronic fatigue syndrome. Conclusion: We demonstrated that our Bayesian based approach is a promising method to assess the gene–gene and gene–environment interactions in chronic fatigue syndrome patients by using genetic factors, such as SNPs, and demographic factors such as age, gender and BMI.

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    Bibliography

    • Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med.121,953–959 (1994).Crossref, Medline, CASGoogle Scholar
    • Afari N, Buchwald D: Chronic fatigue syndrome: a review. Am. J. Psychiatry160(2),221–236 (2003).▪▪ Review on chronic fatigue syndrome.Crossref, MedlineGoogle Scholar
    • Reeves WC, Wagner D, Nisenbaum R et al.: Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Med.3,19 (2005).Crossref, MedlineGoogle Scholar
    • Lin E, Hwang Y, Wang SC, Gu ZJ, Chen EY: An artificial neural network approach to the drug efficacy of interferon treatments. Pharmacogenomics7(7),1017–1024 (2006).Link, CASGoogle Scholar
    • Lin E, Hwang Y, Tzeng CM: A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population. Mol. Diagn. Ther.10(6),367–370 (2006).Crossref, Medline, CASGoogle Scholar
    • Smith AK, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS: Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics7(3),387–394 (2006).Link, CASGoogle Scholar
    • Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF: Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics7(3),475–483 (2006).Link, CASGoogle Scholar
    • Bell JT, Wallace C, Dobson R et al.: Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Hum. Mol. Genet.15,1365–1374 (2006).Crossref, Medline, CASGoogle Scholar
    • Carlborg O, Haley CS: Epistasis: too often neglected in complex trait studies. Nature5,618–625 (2004).CASGoogle Scholar
    • 10  Lin E, Hwang Y, Liang KH, Chen EY: Pattern-recognition techniques with haplotype analysis in pharmacogenomics. Pharmacogenomics8(1),75–83 (2007).▪▪ Review on pattern recognition techniques for detecting gene–gene and gene–environment interactions.Link, CASGoogle Scholar
    • 11  Lin E, Hwang Y, Chen EY: Gene–gene and gene–environment interactions in interferon therapy for chronic hepatitis C. Pharmacogenomics8(10),1327–1335 (2007).Link, CASGoogle Scholar
    • 12  Hickie I, Kirk K, Martin N: Unique genetic and environmental determinants of prolonged fatigue: a twin study. Psychol. Med.29(2),259–268 (1999).Crossref, Medline, CASGoogle Scholar
    • 13  Sullivan PF, Evengård B, Jacks A, Pedersen NL: Twin analyses of chronic fatigue in a Swedish national sample. Psychol. Med.35(9),1327–1336 (2005).Crossref, MedlineGoogle Scholar
    • 14  Schur E, Afari N, Goldberg J, Buchwald D, Sullivan PF: Twin analyses of fatigue. Twin Res. Hum. Genet.10(5),729–733 (2007).Crossref, MedlineGoogle Scholar
    • 15  Briollais L, Wang Y, Rajendram I et al.: Methodological issues in detecting gene–gene interactions in breast cancer susceptibility: a population-based study in Ontario. BMC Med.5,22 (2007).Crossref, MedlineGoogle Scholar
    • 16  Beattie SD, Fong DKH, Lin DKJ: A two-stage Bayesian model selection strategy for supersaturated designs. Technometrics44(1),55–63 (2002).CrossrefGoogle Scholar
    • 17  Swartz MD, Thomas DC, Daw EW et al.: Model selection and Bayesian methods in statistical genetics: summary of group 11 contributions to Genetic Analysis Workshop 15. Genet. Epidemiol.31(Suppl. 1),S96–S102 (2007).Crossref, MedlineGoogle Scholar
    • 18  Yi N, Xu S, Allison DB: Bayesian model choice and search strategies for mapping interacting quantitative trait loci. Genetics165,867–883 (2003).Crossref, Medline, CASGoogle Scholar
    • 19  George EI, McCulloch, RE: Variable selection via Gibbs sampling. J. Am. Stat. Assoc.88,881–889 (1993).CrossrefGoogle Scholar
    • 20  George EI, McCulloch RE: Approaches for Bayesian variable selection. Stat. Sin.7,339–374 (1997).Google Scholar
    • 21  Oh C: A Bayesian genome-wide linkage analysis of quantitative traits for rheumatoid arthritis via perfect sampling. BMC Proc.1(Suppl. 1),S110 (2007).Crossref, MedlineGoogle Scholar
    • 22  Lin E, Huang LC: Identification of significant genes in genomics using Bayesian variable selection methods. Comput. Biol. Chem.1,13–18 (2008).CASGoogle Scholar
    • 23  Oh C, Wang S, Liu N, Chen L, Zhao H: A Bayesian genome screening of maximum number of drinks as an alcoholism phenotype with the new Haseman–Elston method. BMC Genet.6(Suppl. 1),S116 (2005).▪▪ Describes gene–gene and gene–environment interactions using a Bayesian based method.Crossref, MedlineGoogle Scholar
    • 24  Oh C, Ye KQ, He Q, Mendell NR: Locating disease genes using Bayesian variable selection with the Haseman–Elston method. BMC Genet.4(Suppl. 1),S69 (2003).Crossref, MedlineGoogle Scholar
    • 25  Chipman H: Bayesian variable selection with related predictors. Can. J. Stat.24,17–36 (1996).CrossrefGoogle Scholar
    • 26  Thomas A, O’Hara B, Ligges U, Sturtz S: Making BUGS open. R. News6(1),12–17 (2006).Google Scholar
    • 27  Ntzoufras I: Gibbs variable selection using BUGS. J. Stat. Softw.7(7),1–19 (2002).CrossrefGoogle Scholar
    • 28  Dellaportas P, Forster JJ, Ntzoufras I: Bayesian variable selection using the Gibbs sampler. In: Generalized Linear Models: A Bayesian Perspective. Dey DK, Ghosh S, Mallick B (Eds). Marcel Dekker, NY, USA (2000).Google Scholar
    • 29  Millstein J, Conti DV, Gilliland FD, Gauderman WJ: A testing framework for identifying susceptibility genes in the presence of epistasis. Am. J. Hum. Genet.78(1),15–27 (2006).Crossref, Medline, CASGoogle Scholar
    • 30  Rajeevan MS, Smith AK, Dimulescu I et al.: Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav.6(2),167–176 (2007).Crossref, Medline, CASGoogle Scholar
    • 31  Chung Y, Lee SY, Elston RC, Park T: Odds ratio based multifactor-dimensionality reduction method for detecting gene–gene interactions. Bioinformatics23(1),71–76 (2007).Crossref, Medline, CASGoogle Scholar
    • 32  Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wüst S: Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus–pituitary–adrenal axis responses to psychosocial stress. Biol. Psychiatry62(8),863–869 (2007).Crossref, Medline, CASGoogle Scholar
    • 33  van Rossum EF, Voorhoeve PG, te Velde SJ et al.: The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab.89(8),4004–4009 (2004).Crossref, Medline, CASGoogle Scholar
    • 34  Ma DQ, Whitehead PL, Menold MM et al.: Identification of significant association and gene–gene interaction of GABA receptor subunit genes in autism. Am. J. Hum. Genet.77(3),377–388 (2005).Crossref, Medline, CASGoogle Scholar
    • 35  Lee KE, Sha N, Dougherty ER, Vannucci M, Mallick BK: Gene selection: a Bayesian variable selection approach. Bioinformatics19,90–97 (2003).Crossref, Medline, CASGoogle Scholar
    • 36  Chipman H, George E, McCulloch R: The practical implementation of Bayesian model selection. In: IMS Lecture Notes–Monograph Series Lahiri P (Ed.). IMS, OH, USA (2001).Google Scholar
    • 37  Yi N, George V, Allison DB: Stochastic search variable selection for identifying multiple quantitative trait loci. Genetics164(3),1129–1138 (2003).Crossref, Medline, CASGoogle Scholar
    • 38  Marchini J, Donnelly P, Cardon LR: Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat. Genet.37,413–417 (2005).Crossref, Medline, CASGoogle Scholar
    • 39  Evans DM, Marchini J, Morris AP, Cardon LR: Two-stage two-locus models in genome-wide association. PLoS Genet.2(9),E157 (2006).Crossref, MedlineGoogle Scholar
    • 40  Cowles MK, Carlin BP: Markov chain Monte Carlo convergence diagnostics: a comparative study. J. Am. Stat. Assoc.91,883–904 (1996).CrossrefGoogle Scholar
    • 41  Mengersen KL, Robert CP, Guihenneuc-Jouyaux C: MCMC convergence diagnostics: a ‘review’. In: Bayesian Statistics 6. Berger J, Bernardo J, Dawid AP, Smith AFM (Eds). Oxford Sciences Publications, Oxford, UK, 415–441 (1999).Google Scholar
    • 42  Propp JG, Wilson DB: Exact sampling with coupled Markov chains and applications to statistical mechanics. Random Structures Algorithms9,223–252 (1996).CrossrefGoogle Scholar
    • 43  Huang Y, Djuric PM: Variable selection by perfect sampling. EURASIP J. Applied Signal Proc.1,38–45 (2002).Google Scholar
    • 44  van Rossum EF, Binder EB, Majer M et al.: Polymorphisms of the glucocorticoid receptor gene and major depression. Biol. Psychiatry59(8),681–688 (2006).Crossref, Medline, CASGoogle Scholar
    • 45  Licinio J, O’Kirwan F, Irizarry K et al.: Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican–Americans. Mol. Psychiatry9(12),1075–1082 (2004).Crossref, Medline, CASGoogle Scholar
    • 46  Liu Z, Zhu F, Wang G et al.: Association study of corticotropin-releasing hormone receptor 1 gene polymorphisms and antidepressant response in major depressive disorders. Neurosci. Lett.414(2),155–158 (2007).Crossref, Medline, CASGoogle Scholar
    • 101  Dataset from the CDC Chronic Fatigue Syndrome Research Group www.camda.duke.edu/camda06/datasets/index.html.Google Scholar
    • 102  About BMI for adults, Centers for Disease Control and Prevention www.cdc.gov/nccdphp/dnpa/bmi/adult_BMI/about_adult_BMI.htm.Google Scholar